SIMPSON; Iain
Patent Applications and Registrations
Patent applications and USPTO patent grants for SIMPSON; Iain.The latest application filed is for "arginase inhibitors and methods of use thereof".
Company Profile
9.21.51
- SIMPSON; Iain - Cambridge GB
- Simpson; Iain - London GB
- Simpson; Iain - Cambridgeshire GB
- Simpson; Iain - Cheshire GB
- Simpson; Iain - Macclesfield GB
Patent Activity
| Patent | Date |
|---|---|
| Arginase Inhibitors And Methods Of Use Thereof App 20220267356 - MLYNARSKI; Scott Nathan ; et al. | 2022-08-25 |
| Arginase inhibitors and methods of use thereof Grant 11,420,984 - Mlynarski , et al. August 23, 2 | 2022-08-23 |
| Fused Tricyclic Compounds Useful As Anticancer Agents App 20220204527 - KETTLE; Jason Grant ; et al. | 2022-06-30 |
| Arginase Inhibitors And Methods Of Use Thereof App 20220106335 - MLYNARSKI; Scott Nathan ; et al. | 2022-04-07 |
| CXCR4 receptor antagonists Grant 10,995,091 - Savory , et al. May 4, 2 | 2021-05-04 |
| Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as SSAO inhibitors Grant 10,968,223 - Espensen , et al. April 6, 2 | 2021-04-06 |
| Arginase Inhibitors and Methods of Use Thereof App 20210002305 - MLYNARSKI; Scott Nathan ; et al. | 2021-01-07 |
| Imidazo[4,5-c]pyridine And Pyrrolo[2,3-c]pyridine Derivatives As Ssao Inhibitors App 20200347059 - ESPENSEN; Max ; et al. | 2020-11-05 |
| Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as SSAO inhibitors Grant 10,766,897 - Espensen , et al. Sep | 2020-09-08 |
| Compounds App 20200262835 - ESPENSEN; Max ; et al. | 2020-08-20 |
| Compounds Grant 10,590,125 - Espensen , et al. | 2020-03-17 |
| Imidazo[4,5-c]pyridine And Pyrrolo[2,3-c]pyridine Derivatives As Ssao Inhibitors App 20200002335 - ESPENSEN; Max ; et al. | 2020-01-02 |
| Imidazo[4,5-C]pyridine and pyrrolo[2,3-C]pyridine derivatives as SSAO inhibitors Grant 10,428,066 - Espensen , et al. October 1, 2 | 2019-10-01 |
| Cxcr4 Receptor Antagonists App 20190062333 - SAVORY; Edward Daniel ; et al. | 2019-02-28 |
| CXCR4 receptor antagonists Grant 10,155,761 - Savory , et al. Dec | 2018-12-18 |
| Imidazo[4,5-c]pyridine And Pyrrolo[2,3-c]pyridine Derivatives As Ssao Inhibitors App 20180194763 - Espensen; Max ; et al. | 2018-07-12 |
| Imidazo[4,5-C]pyridine and pyrrolo[2,3-C]pyridine derivatives as SSAO inhibitors Grant 9,951,068 - Espensen , et al. April 24, 2 | 2018-04-24 |
| Imidazo[4,5-c]pyridine Derived Ssao Inhibitors App 20170275281 - Patient; Lee ; et al. | 2017-09-28 |
| Imidazo[4,5-c]pyridine And Pyrrolo[2,3-c]pyridine Derivatives As Ssao Inhibitors App 20170247378 - Espensen; Max ; et al. | 2017-08-31 |
| CXCR4 Receptor Antagonists App 20170226106 - Savory; Edward Daniel ; et al. | 2017-08-10 |
| Imidazo[4,5-C]pyridine and pyrrolo[2,3-C]pyridine derivatives as SSAO inhibitors Grant 9,676,769 - Espensen , et al. June 13, 2 | 2017-06-13 |
| Compounds Grant 9,580,415 - Patient , et al. February 28, 2 | 2017-02-28 |
| New Compounds App 20160326172 - Espensen; Max ; et al. | 2016-11-10 |
| Substituted imidazo[4,5-c]pyridine compounds and compositions thereof Grant 9,428,498 - Espensen , et al. August 30, 2 | 2016-08-30 |
| CXCR4 receptor antagonists Grant 9,353,086 - Savory , et al. May 31, 2 | 2016-05-31 |
| Imidazo[4,5-c]pyridine And Pyrrolo[2,3-c]pyridine Derivatives As Ssao Inhibitors App 20160046622 - Espensen; Max ; et al. | 2016-02-18 |
| CXCR4 Receptor Antagonists App 20160046606 - Savory; Edward Daniel ; et al. | 2016-02-18 |
| New Compounds App 20160024080 - Patient; Lee ; et al. | 2016-01-28 |
| Inhibitor compounds of semicarbazide-sensitive amine oxidases Grant 9,227,967 - Evans , et al. January 5, 2 | 2016-01-05 |
| Enzyme inhibitor compounds Grant 9,150,574 - Evans , et al. October 6, 2 | 2015-10-06 |
| Imidazopyridine Compounds App 20150239905 - Nilsson; Marianne ; et al. | 2015-08-27 |
| New Enzyme Inhibitor Compounds App 20140357623 - Evans; David ; et al. | 2014-12-04 |
| New Compounds App 20140275040 - Espensen; Max ; et al. | 2014-09-18 |
| New Enzyme Inhibitor Compounds App 20140275063 - Carley; Allison ; et al. | 2014-09-18 |
| Imidazopyridine Compounds App 20140206662 - Nilsson; Marianne ; et al. | 2014-07-24 |
| New Compounds II App 20140107150 - Savory; Edward ; et al. | 2014-04-17 |
| Protease Activated Receptor 2 (PAR2) Antagonists App 20130324556 - Boyd; Joe William ; et al. | 2013-12-05 |
| CXCR4 Receptor Antagonists App 20130289020 - Savory; Edward Daniel ; et al. | 2013-10-31 |
| 7-hydroxy-pyrazolo[1,5-a] Pyrimidine Compounds And Their Use As Ccr2 Receptor Antagonists App 20130252951 - Boyd; Joe William ; et al. | 2013-09-26 |
| New Enzyme Inhibitor Compounds App 20130102587 - Evans; David ; et al. | 2013-04-25 |
| Compounds useful for the treatment of conditions associated with weight gain Grant 8,093,248 - Boyd , et al. January 10, 2 | 2012-01-10 |
| Piperazine Derivatives And Their Use As Leptin Receptor Modulators App 20110275638 - Chapman; Emma ; et al. | 2011-11-10 |
| Piperazine Derivatives And Their Use As Leptin Receptor Modulators App 20110275637 - Chapman; Emma ; et al. | 2011-11-10 |
| New Pyridine Derivatives as Leptin Receptor Modulator Mimetics App 20110275678 - Higginbottom; Michael ; et al. | 2011-11-10 |
| New Compounds VII App 20110275670 - Chapman; Emma ; et al. | 2011-11-10 |
| New Compounds Ii App 20110195992 - Savory; Edward ; et al. | 2011-08-11 |
| 2-anilinopurin-8-ones As Inhibitors Of Ttk/mps1 For The Treatment Of Proliferative Disorders App 20110118238 - Andrews; David Michael ; et al. | 2011-05-19 |
| Chemical Compounds App 20100137397 - Birch; Alan Martin ; et al. | 2010-06-03 |
| Compounds Grant 7,709,471 - Halsall , et al. May 4, 2 | 2010-05-04 |
| Novel Compounds 515 App 20100105655 - Ducray; Richard ; et al. | 2010-04-29 |
| Dihydropteridine Compounds As Anti Proliferative Agents App 20090312336 - Simpson; Iain ; et al. | 2009-12-17 |
| Compounds II App 20090281087 - Boyd; Joseph W. ; et al. | 2009-11-12 |
| Compounds IV App 20090203695 - Higginbottom; Michael ; et al. | 2009-08-13 |
| Indan-Amide Derivatives with Glycogen Phosphorylase Inhibitory Activity App 20090124682 - Birch; Alan Martin ; et al. | 2009-05-14 |
| Heterocyclic Amide Derivatives Which Possess Glycogen Phosphorylase Inhibitory Activity App 20080064691 - Birch; Alan Martin ; et al. | 2008-03-13 |
| Novel Compounds App 20080009482 - HALSALL; Christopher Thomas ; et al. | 2008-01-10 |
| Heterocyclic amide derivatives which process glycogen phorylase inhibitory activity App 20060264494 - Bennett; Stuart Norman Lile ; et al. | 2006-11-23 |
| Indolamid derivatives which possess glycogenphosphorylase inhibitory activity Grant 7,138,415 - Whittamore , et al. November 21, 2 | 2006-11-21 |
| Heterocyclic amide derivatives having glycogen phosphorylase inhibitory activity Grant 7,122,567 - Whittamore , et al. October 17, 2 | 2006-10-17 |
| Indolamide derivatives which possess glycogen phosphorylase inhibitory activity App 20060211760 - Birch; Alan Martin ; et al. | 2006-09-21 |
| Indol-2-amides as glycogen phosphorylase inhibitors App 20060199966 - Bennett; Stuart Norman Lile ; et al. | 2006-09-07 |
| Indolamid derivatives which possess glycogenphosphorylase inhibitory activity App 20050107362 - Whittamore, Paul Robert Owen ; et al. | 2005-05-19 |
| Antibacterial composition App 20040176349 - Simpson, Iain ; et al. | 2004-09-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 